Dermatitis: all 1,425 studies

Page 2 of 15. Open to participants first (127), then studies with results posted, then the rest; newest registration first within each.

• A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic DermatitisNot yet recruitingNCT05525715Phase 1/2
• Vitamin D Treatment Effect for Atopic Dermatitis in ChildrenRecruitingNCT05523986Not applicable
• The Effect of Intervention and Mechanism of ICBT on Chronic Itching in Patients With Atopic DermatitisNot yet recruitingNCT05502848Not applicable
• Meditation in Inflammatory DermatosisRecruitingNCT05500794Not applicable
• Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)AvailableNCT05466578
• Effects of a Mixed Chinese Herbal Formula on Atopic DermatitisNot yet recruitingNCT05455060Phase 3
• Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.RecruitingNCT05330637
• China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment ProjectRecruitingNCT05316805
• Dupixent and Narrowband UVB for Atopic DermatitisRecruitingNCT05285839Phase 4
• SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis SubjectsRecruitingNCT05215808Phase 1
• A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological ConditionsEnrolling by invitationNCT05084417
• The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer PatientsRecruitingNCT05032768
• Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD InjNot yet recruitingNCT04730024
• A Prospective Sample Collection Study Using Non-invasive Methods to Investigate Biomarkers in AD PatientsRecruitingNCT04699695
• Epidermal Skin Grafts to Improve Healing In Radiation WoundsRecruitingNCT04560803Not applicable
• Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic DermatitisRecruitingNCT04307862Phase 2
• Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab TreatmentRecruitingNCT04276623
• Prospective Longitudinal Observational Research in Atopic DermatitisRecruitingNCT04240522
• Long-Term Safety Follow-Up Study of SCM-AGH in Subjects Who Participated and Administered SCM-AGH in to Severe Atopic Dermatitis Clinical TrialsEnrolling by invitationNCT04185584
• Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia AreataEnrolling by invitationNCT03976622
• TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)RecruitingNCT03795506Not applicable
• BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic DermatitisRecruitingNCT03549416
• StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers PatientsRecruitingNCT03394417Not applicable
• TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic DermatitisRecruitingNCT03057860
• Epicutaneous Testing of Cosmetics for Skin CompatibilityRecruitingNCT03024671Not applicable
• Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD)RecruitingNCT02365246Phase 2
• Effects of Treatments on Atopic DermatitisRecruitingNCT01631617Phase 2
• Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.TerminatedNCT06447506Phase 2Results posted
• A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic DermatitisTerminatedNCT05999799Phase 2Results posted
• Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic DermatitisCompletedNCT05990725Phase 3Results posted
• A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)TerminatedNCT05984784Phase 1/2Results posted
• Topical Ruxolitinib Evaluation in Chronic Hand EczemaCompletedNCT05906628Phase 2Results posted
• A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic DermatitisCompletedNCT05870865Phase 2Results posted
• Ruxolitinib in Seborrheic DermatitisCompletedNCT05787860Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)CompletedNCT05764161Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)CompletedNCT05755438Phase 3Results posted
• A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by InjectionTerminatedNCT05732454Phase 2/3Results posted
• A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic DermatitisCompletedNCT05656911Phase 2Results posted
• A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic DermatitisCompletedNCT05601882Phase 3Results posted
• Safety and Efficacy Study of EVO101 Topical Cream in Atopic DermatitisCompletedNCT05579899Phase 2Results posted
• The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact DermatitisCompletedNCT05498467Phase 3Results posted
• Comparing Tissue Adhesives in Port Site ClosureCompletedNCT05492721Phase 3Results posted
• A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe ADCompletedNCT05470114Phase 2Results posted
• Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS)CompletedNCT05469464Phase 2Results posted
• Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008)CompletedNCT05450198Phase 1Results posted
• A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 TrialsTerminatedNCT05439941Phase 2Results posted
• A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.CompletedNCT05375955Phase 2Results posted
• A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in IndiaCompletedNCT05375929Phase 3Results posted
• A Long-term Trial of OPA-15406 in Infants With Atopic DermatitisCompletedNCT05372653Phase 3Results posted
• Topical Ruxolitinib in Chronic Hand DermatitisCompletedNCT05293717Phase 1/2Results posted
• Clinical Investigation on the Efficacy and Safety of Relizema Cream in Paedriatric PatientsCompletedNCT05259774Not applicableResults posted
• Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous GelTerminatedNCT05253755Phase 2Results posted
• Improvement In Scratch Behavior And Sleep In Patients With Atopic DermatitisTerminatedNCT05200403Phase 4Results posted
• Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA)CompletedNCT05194540Phase 3Results posted
• Targeted Investigation of Microbiome EliminationTerminatedNCT05177328Phase 1Results posted
• A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic DermatitisTerminatedNCT05155085Phase 2Results posted
• A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for CyclosporineCompletedNCT05149313Phase 3Results posted
• Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis InvolvementCompletedNCT05127421Phase 2Results posted
• A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic DermatitisCompletedNCT05121480Phase 2Results posted
• Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic DermatitisCompletedNCT05117060Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in ChinaCompletedNCT05017480Phase 2Results posted
• A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic DermatitisCompletedNCT05014438Phase 2Results posted
• Clinical Investigation on the Efficacy and Safety of Relizema EcofoamCompletedNCT05001139Not applicableResults posted
• A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic DermatitisTerminatedNCT04990440Phase 2Results posted
• Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)CompletedNCT04973228Phase 3Results posted
• The Incidence of Venous Thromboembolism in Atopic DermatitisCompletedNCT04969653Results posted
• An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.CompletedNCT04922021Phase 2Results posted
• A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)CompletedNCT04921969Phase 3Results posted
• The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic DermatitisCompletedNCT04839380Phase 2Results posted
• A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.CompletedNCT04836858Phase 2Results posted
• Clinical Investigation on the Performance and Safety of DermoRelizema EcofoamCompletedNCT04826471Not applicableResults posted
• A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic DermatitisCompletedNCT04800315Phase 2Results posted
• EpiCeram for Skin Protection in Healthcare WorkersTerminatedNCT04793711Not applicableResults posted
• A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic DermatitisTerminatedNCT04791319Phase 2Results posted
• Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)CompletedNCT04773600Phase 3Results posted
• A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT04760314Phase 3Results posted
• Study of TER-101 Topical Ointment in Subjects With Atopic DermatitisCompletedNCT04753034Phase 2Results posted
• Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic DermatitisCompletedNCT04668066Phase 1Results posted
• Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque PsoriasisCompletedNCT04664153Phase 2Results posted
• A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)CompletedNCT04626297Phase 3Results posted
• Evaluation of Skin Cleansers and Skin Protectants in Management of Incontinence-associated DermatitisTerminatedNCT04625426Not applicableResults posted
• Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic DermatitisTerminatedNCT04605094Phase 2Results posted
• Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic DermatitisCompletedNCT04598269Phase 2Results posted
• Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic DermatitisCompletedNCT04587453Phase 3Results posted
• A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT04562116Phase 2Results posted
• Study to Find Out if Cream V61-044 Used to Treat Fungal Infections Causes an Allergic Skin Reaction to Sunlight in Healthy ParticipantsCompletedNCT04532164Phase 3Results posted
• Study to Learn More About the Potential of Antifungal Cream V61-044 Containing Trolamine to Cause Irritant Reaction of the Skin to Ultra Violet Light in Healthy Human SubjectsCompletedNCT04531527Phase 3Results posted
• A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic DermatitisTerminatedNCT04498403Phase 3Results posted
• B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic DermatitisCompletedNCT04490109Phase 2Results posted
• Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis.CompletedNCT04483856Not applicableResults posted
• Preventative Skin Care for Children Undergoing Targeted CNS Tumor TherapyCompletedNCT04479514Phase 2Results posted
• Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic DermatitisCompletedNCT04445987Phase 2Results posted
• A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic DermatitisCompletedNCT04444752Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)CompletedNCT04417894Phase 3Results posted
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)CompletedNCT04392154Phase 3Results posted
• Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic DermatitisCompletedNCT04360187Phase 3Results posted
• Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical TherapyCompletedNCT04345367Phase 3Results posted
• Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic DermatitisCompletedNCT04313400Phase 1/2Results posted
• Apremilast 30 mg Twice Daily (BID) Combined With DupilumabCompletedNCT04306965Phase 2Results posted
• Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT04250350Phase 3Results posted

← Dermatitis overview